1)Shimohara Y, Urabe Y, Oka S, et al. Clinicopathological characteristics of colorectal serrated polyposis syndrome(SPS):results of a multicenter study by the SPS Study Group in Japan. J Gastroenterol 57:300-308, 2022
2)卜部祐司,岡志郎,田中信治,他.Serrated Polyposis Syndromeの最新知見.胃と腸 55:1622-1630, 2020
3)Williams GT, Arthur JF, Bussey HJ, et al. Metaplastic polyps and polyposis of the colorectum. Histopathology 4:155-170, 1980
4)IJspeert JEG, Bevan R, Senore C, et al. Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts:a European overview. Gut 66:1225-1232, 2017
5)Rosty C, Brosens LAA, Nagtegaal ID. Serrated polyposis. In WHO Classification of Tumours Editorial Board(eds). WHO Classification of Tumours, Digestive System Tumours, 5th ed. IARC press, Lyon, 2019
6)Miwata T, Hiyama T, Oka S, et al. Clinicopathologic features of hyperstic/serrated polyposis syndrome in Japan. J Gastroenterol Hepatol 28:1693-1698, 2013
7)Yan HHN, Lai JCW, Ho SL, et al. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation. Gut 66:1645-1656, 2017
8)Yu J, Chen Y, Fu X, et al. Invasive Fusobacterium nucleatum may play a role in the carcinogenesis of proximal colon cancer through the serrated neoplasia pathway. Int J Cancer 139:1318-1326, 2016
9)Carballal S, Rodríguez-Alcalde D, Moreira L, et al. Colorectal cancer risk factors in patients with serrated polyposis syndrome:a large multicentre study. Gut 65:1829-1837, 2016
10)Murakami T, Sakamoto N, Ritusno H, et al. Distinct endoscopic characteristics of sessile serrated adenoma/polyp with and without dysplasia/carcinoma. Gastrointest Endosc 85:590-600, 2017
11)Chino A, Osumi H, Kishihara T, et al. Advantages of magnifying narrow-band imaging for diagnosing colorectal cancer coexisting with sessile serrated adenoma/polyp. Dig Endosc 28(Suppl 1):53-59, 2016
12)藤井茂彦,日下利広,田中泰敬,他.SSL with carcinomaの内視鏡診断.消内視鏡 34:935-943, 2022